Royalty Pharma plc
Ticker: 1802768
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 630.58+3.5% | 609.29+5.3% | 578.67+1.8% | 568.25+0.6% | 564.69+5.1% | 537.27-5.4% | 567.98+5.9% | 536.31 |
| Total Income | 630.58+3.5% | 609.29+5.3% | 578.67+1.8% | 568.25+0.6% | 564.69+5.1% | 537.27-5.4% | 567.98+5.9% | 536.31 |
| EXPENSES | ||||||||
| Expenditure | 67.54-62.9% | 182.14-50.6% | 368.87+982.7% | 34.07+120.0% | -170.38-163.7% | 267.64-58.3% | 641.75+66.7% | 384.87 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | 468.26+5.4% | 444.21+390.1% | 90.64-79.1% | 433.43-46.2% | 806.36+314.8% | 194.38+4652.2% | -4.27-103.5% | 122.08 |
| Net Profit | 294.69+2.2% | 288.22+855.0% | 30.18-87.3% | 238.35-56.2% | 543.99+433.3% | 102.00+2033.9% | 4.78-93.4% | 72.11 |
| KEY METRICS | ||||||||
| OPM % | 89.29%+19.18pp | 70.11%+33.85pp | 36.26%-57.75pp | 94.00%-5.99pp | 100.00%+49.81pp | 50.19%+63.17pp | -12.99%-41.23pp | 28.24% |
| NPM % | 46.73%-0.57pp | 47.30%+42.09pp | 5.21%-36.73pp | 41.95%-54.39pp | 96.33%+77.35pp | 18.99%+18.14pp | 0.84%-12.61pp | 13.45% |
| EPS | 0.67+0.0% | 0.67+857.1% | 0.07-87.3% | 0.55-54.9% | 1.22+430.4% | 0.23+2200.0% | 0.01-93.8% | 0.16 |
Corporate Events
Board MeetingRPRX
20264Jun
Board Meeting
Voting results from the 2026 Annual General Meeting of Share…
SEC Filing ↗